SCHEMBL4137219

SCHEMBL4137219

N#Cc1c(O)c(-c2ccsc2)nn(Cc2ccc(F)cc2)c1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 5/20 0.45
ADORA2A P29274 3/20 0.42
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 2/20 0.40
HSD17B10 Q99714 1/20 0.40
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
POLB P06746 1/20 0.38
PKM P14618 2/20 0.38
PKLR P30613 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.37
HTT P42858 3/20 0.36
NPSR1 Q6W5P4 3/20 0.36
PTGES O14684 2/20 0.36
MITF O75030 1/20 0.35
RAB9A P51151 1/20 0.35
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13905624 0.89 ADORA2A (0.40) ADORA1ADORA2AALDH1A1HTTNPSR1
SCHEMBL4143666 0.88 ADORA2A (0.41) ADORA1ADORA2AALDH1A1MEN1KMT2A
SCHEMBL4143701 0.88 ADORA1 (0.46) ADORA1ADORA2AALDH1A1KDM4EHSD17B10
SCHEMBL13905625 0.86 ADORA2A (0.39) ADORA1ADORA2AALDH1A1KDM4EHSD17B10
SCHEMBL4125999 0.80 USP2 (0.45) ADORA1ADORA2AALDH1A1KDM4EHSD17B10
SCHEMBL4142975 0.80 ADORA1 (0.40) ADORA1ADORA2AALDH1A1KDM4EMEN1
SCHEMBL13905617 0.79 MERTK (0.41) ADORA1ADORA2APTGES
SCHEMBL4052051 0.78 ADORA1 (0.38) ADORA1ADORA2APTGES
SCHEMBL4126223 0.78 GRM2 (0.40) ADORA1ADORA2APTGES
SCHEMBL4123420 0.78 PDE4A (0.44) ADORA1ADORA2AKDM4EHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090060867-A1 PHOSPHADIAZINE HCV POLYMERASE INHIBITORS III AND VI IDENIX PHARMACEUTICALS, INC. (US) 2009-03-05 US disclosed
US-20090060867-A1 PHOSPHADIAZINE HCV POLYMERASE INHIBITORS III AND VI IDENIX PHARMACEUTICALS, INC. (US) 2009-03-05 US disclosed
US-20090060867-A1 PHOSPHADIAZINE HCV POLYMERASE INHIBITORS III AND VI IDENIX PHARMACEUTICALS, INC. (US) 2009-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090060867-A1 PHOSPHADIAZINE HCV POLYMERASE INHIBITORS III AND VI POLR2E, POLR2H, POLI ADORA1 3760/4885ADORA2A 2513/4885ALDH1A1 1965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.